TY  - JOUR
IS  - 7
N2  - Diabetic retinopathy (DR) remains one of the leading causes of preventable vision loss and blindness among working-age adults worldwide. This review highlights current concepts in the pathogenesis, classification, and, most importantly, modern evidence-based therapeutic strategies for managing diabetic retinopathy, including systemic risk factor control, laser photocoagulation, intravitreal anti-VEGF agents, corticosteroid therapy, and vitrectomy. The article also discusses emerging technologies such as sustained-release drug implants and gene therapy prospects. Emphasis is placed on the importance of timely screening, multidisciplinary collaboration, and patient education to improve outcomes and preserve vision.
TI  - MODERN APPROACHES TO THE TREATMENT OF DIABETIC RETINOPATHY
JF  - PROBLEMS AND SOLUTIONS OF SCIENTIFIC AND INNOVATIVE RESEARCH
KW  - diabetic retinopathy
KW  -  anti-VEGF therapy
KW  -  laser photocoagulation
KW  -  intravitreal corticosteroids
KW  -  vitrectomy
KW  -  vision preservation.
EP  - 51
ID  - arxiv95193
UR  - https://universalconference.us/index.php/pssir/article/view/4955
A1  - Murodov Murodjon, Murodov Murodjon
SP  - 47
VL  - 2
Y1  - 2025/07/18/
AV  - public
ER  -